BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Obelis Group - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Obelis Group
X-ORIGINAL-URL:https://www.obelis.net
X-WR-CALDESC:Events for Obelis Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260731T000000
DTEND;TZID=Europe/Brussels:20260731T235959
DTSTAMP:20260420T151517Z
CREATED:20260420T132148Z
LAST-MODIFIED:20260420T151517Z
UID:10000046-1785456000-1785542399@www.obelis.net
SUMMARY:EU Fragrance Allergens Deadline
DESCRIPTION:Starting on 31 July 2026\, cosmetic products placed on the EU market must comply with the updated labelling requirements\, including the disclosure of 56 additional fragrance allergens where applicable. \n\n\n\nFrom this date onwards: \n\n\n\n✅ Products that do not meet the updated labelling requirements may be held at customs\, refused entry\, or removed from the market \n\n\n\n✅ Every new product entering EU customs is treated as a fresh placement on the market; consequently\, all batches arriving after the deadline must meet the updated labeling requirements\, regardless of whether the product was previously available. \n\n\n\nNeed a tailored assessment or product-specific guidance? Our experts are here to help.Not sure if your products are compliant? Contact Obelis for a detailed evaluation.
URL:https://www.obelis.net/events/eu-cosmetics-fragrance-allergens-deadline-2026-labeling-compliance/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/04/Deadline-fragrance-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260604T150000
DTEND;TZID=Europe/Brussels:20260604T160000
DTSTAMP:20260520T092205Z
CREATED:20260520T092200Z
LAST-MODIFIED:20260520T092205Z
UID:10000049-1780585200-1780588800@www.obelis.net
SUMMARY:Webinar - Global Cosmetic Safety: Mastering Multiterritory Assessment & Laboratory Testing
DESCRIPTION:Join us for an expert-led session on navigating cosmetic safety in a complex global regulatory landscape. \n\n\n\nAs cosmetic products cross borders\, ensuring compliance is no longer a one-time task\, it requires a strategic\, science-driven approach that integrates multiterritory safety assessment\, robust laboratory testing\, and continuously updated documentation. \n\n\n\nIn this webinar\, we will explore how laboratory testing supports product safety and regulatory acceptance across different markets\, and how to effectively manage multiterritory cosmetic safety assessments without duplicating efforts. You’ll also gain insights into the concept of “living documentation”\, and why maintaining up-to-date safety files is essential to stay compliant in an evolving regulatory environment.
URL:https://www.obelis.net/events/webinar-global-cosmetic-safety-mastering-multiterritory-assessment-laboratory-testing/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/05/Event-Calendar-Featured-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260528T000000
DTEND;TZID=Europe/Brussels:20260528T235959
DTSTAMP:20260127T081211Z
CREATED:20260127T081040Z
LAST-MODIFIED:20260127T081211Z
UID:10000036-1779926400-1780012799@www.obelis.net
SUMMARY:EUDAMED Registration Becomes Mandatory – May 2026
DESCRIPTION:Regulatory Alert | EUDAMED becomes mandatory\n\n\n\nCommission Decision (EU) 2025/2371 confirms the full functionality of the first four EUDAMED modules. As a result\, economic operators must comply with mandatory registration requirements. \n\n\n\nMandatory modules from 28 May 2026: \n\n\n\n✅Market Surveillance \n\n\n\n✅Actors: registration of manufacturers\, authorised representatives\, importers \n\n\n\n✅UDI / Devices: device registration (excluding custom-made devices) \n\n\n\n✅Notified Bodies & Certificates \n\n\n\nA six-month transition period (until November 27\, 2026) applies only to devices placed on the market before May 28\, 2026. Devices placed on the market after this date must be registered before market access. \n\n\n\nObelis supports manufacturers at every step of EUDAMED compliance!
URL:https://www.obelis.net/events/eudamed-registration-becomes-mandatory-may-2026/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/341.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260526T000000
DTEND;TZID=Europe/Brussels:20260526T235959
DTSTAMP:20260127T082030Z
CREATED:20260127T081634Z
LAST-MODIFIED:20260127T082030Z
UID:10000037-1779753600-1779839999@www.obelis.net
SUMMARY:IVDR Class C Transitional Deadline – May 2026
DESCRIPTION:As the transition to the In Vitro Diagnostic Regulation (IVDR) continues\, we would like to remind you of the critical 2026 deadlines for legacy IVDs that are classified to Class C under IVDR. \n\n\n\nFor these devices\, the following milestones apply:  \n\n\n\n✅A written agreement between the manufacturer and the Notified Body must be signed by 26 September 2026. \n\n\n\n✅The manufacturer or their Authorised Representative must apply to a Notified Body for IVDR conformity assessment by 26 May 2026. \n\n\n\nObelis guides manufacturers through the IVDR transition\, including selecting and engaging with a Notified Body.
URL:https://www.obelis.net/events/ivdr-class-c-transitional-deadline-may-2026/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/331.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260501T000000
DTEND;TZID=Europe/Brussels:20260501T235959
DTSTAMP:20260121T084723Z
CREATED:20260119T105105Z
LAST-MODIFIED:20260121T084723Z
UID:10000030-1777593600-1777679999@www.obelis.net
SUMMARY:Omnibus Act VIII – May 2026
DESCRIPTION:European Union – Omnibus Act VIII amends the Cosmetic Regulations\n\n\n\n✅1 May 2026: Products containing 3-(4′-methylbenzylidene)-camphor [INCI: 4-Methylbenzylidene Camphor] (CAS No 36861-47-9/38102-62-4) can no longer be made available on the market. \n\n\n\n✅1 May 2026: With no distinction between placing products on the market and making them available\, Omnibus Act VIII will apply. This means that\, from the application date\, non-compliant cosmetics can no longer be sold in the EU market and must be recalled beforehand. \n\n\n\nMeeting regulatory deadlines is essential to avoid market disruptions and product recalls\, and Obelis is here to support you every step of the way in ensuring timely compliance with Omnibus Act VIII requirements. \n\n\n\n\n\n\n\n\nNew amendment to EU Cosmetics Regulation: Retinol and other substances banned or restricted in cosmetics – COSlaw.eu – Guiding through EU Cosmetics Regulations: EUDAMED Deadline
URL:https://www.obelis.net/events/omnibus-act-viii-may-2026/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/271.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260412T000000
DTEND;TZID=Europe/Brussels:20260412T235959
DTSTAMP:20260121T085012Z
CREATED:20260119T135238Z
LAST-MODIFIED:20260121T085012Z
UID:10000032-1775952000-1776038399@www.obelis.net
SUMMARY:Canada Fragrance Allergen Disclosure – April 2026
DESCRIPTION:Canada – Fragrance Allergen Disclosure Deadline\n\n\n\n✅12 April 2026: New and existing cosmetics have to disclose the 24 fragrance allergens listed below within the list of ingredients\, when present at concentration greater than 0.01% in rinse-off products and 0.001% in leave-on products. \n\n\n\nTo ensure compliance with the above regulatory changes\, we recommend reviewing and\, where necessary\, revising your product formulations. Obelis is here to support you at every step of the process.
URL:https://www.obelis.net/events/canada-fragrance-allergen-disclosure-april-2026/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/291.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260121T000000
DTEND;TZID=Europe/Brussels:20260331T235959
DTSTAMP:20260121T084922Z
CREATED:20260119T120409Z
LAST-MODIFIED:20260121T084922Z
UID:10000031-1768953600-1775001599@www.obelis.net
SUMMARY:Benzophenone‑3 & Methyl Salicylate Restrictions  – January and March 2026
DESCRIPTION:United Kingdom – Benzophenone‑3 & Methyl Salicylate Restrictions Deadlines\n\n\n\n✅21 January 2026: Cosmetic products containing Benzophenone-3 and not complying with the restrictions outlined in Annex VI can no longer be placed on Great Britain’s market. For full details on the restrictions\, please refer to this link. \n\n\n\n✅31 March 2026: Cosmetic products containing Methyl Salicylate (CAS 119-36-8)and not complying with the restrictions outlined in Annex III can no longer be made available on Great Britain’s market. For full details on the restrictions\, please refer to this link. \n\n\n\nCheck your product portfolio now to ensure compliance with the upcoming UK cosmetic ingredient restrictions and avoid market disruptions. Appoint Obelis now to manage your compliance.
URL:https://www.obelis.net/events/benzophenone%e2%80%913-methyl-salicylate-restrictions-january-and-march-2026/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/281.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260101T000000
DTEND;TZID=Europe/Brussels:20260101T235959
DTSTAMP:20260121T132516Z
CREATED:20260121T132507Z
LAST-MODIFIED:20260121T132516Z
UID:10000033-1767225600-1767311999@www.obelis.net
SUMMARY:France: Ban Effective Date – January 2026
DESCRIPTION:France – PFAS prohibition effective date\n\n\n\n✅01 January 2026: New prohibition for making available on the market products containing intentionally added PFAS \n\n\n\n \n\n\n\nThe 01 January 2026 PFAS ban is approaching\, and timely compliance is key to keeping your products on the market without interruption. Obelis is here to provide expert guidance and practical support\, ensuring you meet the new requirements efficiently and confidently.
URL:https://www.obelis.net/events/france-ban-effective-date-january-2026/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/301.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260101T000000
DTEND;TZID=Europe/Brussels:20260101T235959
DTSTAMP:20260121T131130Z
CREATED:20260121T131125Z
LAST-MODIFIED:20260121T131130Z
UID:10000034-1767225600-1767311999@www.obelis.net
SUMMARY:Switzerland: Effective Date of Furocoumarin Restriction
DESCRIPTION:Switzerland – Effective Date of Furocoumarin Restriction\n\n\n\n✅1 January 2026: In finished cosmetic products\, excluding perfumes\, eaux de toilette and eau de cologne\, the sum of the concentrations of the furocoumarins Byakangelicol\, Epoxy-bergamottin\, Isopimpinellin\, 5-Methoxypsoralen\, 8-Methoxypsoralen\, Oxypeucedanin\, Oxypeucedanin hydrate and Psoralen must be present in quantities below 1 mg/kg\, and natural essential oils must be dosed accordingly\, where\, under normal or reasonably foreseeable conditions of use\, the cosmetic product: is not rinsed off; and may be directly exposed to sunlight. \n\n\n\n \n\n\n\nContact Obelis for expert guidance to ensure full compliance with the upcoming furocoumarin restrictions.
URL:https://www.obelis.net/events/switzerland-effective-date-of-furocoumarin-restriction/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/311.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250526T000000
DTEND;TZID=Europe/Brussels:20250526T235959
DTSTAMP:20250519T092253Z
CREATED:20250221T132101Z
LAST-MODIFIED:20250519T092253Z
UID:10000012-1748217600-1748303999@www.obelis.net
SUMMARY:IVDR Legacy Extension Deadline – May 2025
DESCRIPTION:For in vitro diagnostic (IVD) manufacturers navigating the transition to the In Vitro Diagnostic Regulation (IVDR)\, a key deadline is approaching. The IVDR legacy extension applies only if manufacturers meet specific requirements: \n\n\n\nSubmission of an application to a Notified Body \n\n\n\n✅ Class D devices (high-risk IVDs that were self-certified under IVDD but now require a Notified Body under IVDR)- by 26 September 2025 \n\n\n\n✅ Class C devices – by 26 May 2026 \n\n\n\n✅ Class B & Class A sterile devices – by 26 May 2027 \n\n\n\n✅All classes of IVD legacy devices – Implementation of an IVDR-compliant Quality Management System (QMS) – by 26 May 2025 \n\n\n\nFailing to meet these and existing legacy conditions means the extension will not apply\, and full IVDR compliance will be required. Manufacturers should act now to ensure a smooth transition and avoid market disruptions. \n\n\n\nIs your company on track for compliance? Let’s discuss how to navigate this critical regulatory shift. \n\n\n\n \n\n\n\n\n\n\n\n\nLegacy device manufacturers: Important deadlines & steps · MDlaw – Information platform on European medical device regulations: EUDAMED Deadline
URL:https://www.obelis.net/events/ivdr-legacy-extension-deadline-may-2025/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/svg+xml:https://www.obelis.net/wp-content/uploads/2025/02/Event-Calendar-Featured-Image-8.svg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250420T000000
DTEND;TZID=Europe/Brussels:20250420T235959
DTSTAMP:20250327T104820Z
CREATED:20250225T162203Z
LAST-MODIFIED:20250327T104820Z
UID:10000014-1745107200-1745193599@www.obelis.net
SUMMARY:UK Cosmetics Market: banned CMRs – April 2025
DESCRIPTION:On October 3\, 2024\, the United Kingdom took a significant step toward tightening cosmetic safety by notifying the World Trade Organization (WTO) of a draft amendment to its GB Cosmetics Regulation.  \n\n\n\nThis update introduces 13 more chemicals to the growing list of banned substances\, all of which are classified as carcinogenic\, mutagenic\, or reprotoxic (CMR). \n\n\n\nThis move follows an earlier major shift in 2024\, when 52 CMR chemicals were banned through the same legislative change. However\, it’s important to note that there are still 13 substances banned in the EU that remain legal in the UK\, leaving room for further regulatory alignment. \n\n\n\nWant more details on which ingridients are banned? \n\n\n\n\n\n\n\n\nUK Bans 13 Additional CMR Chemicals in Cosmetics – COSlaw.eu – Guiding through EU Cosmetics Regulations: EUDAMED Deadline
URL:https://www.obelis.net/events/uk-crm-pom-april-2025/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/svg+xml:https://www.obelis.net/wp-content/uploads/2025/02/Event-Calendar-Featured-Image-9.svg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250301T000000
DTEND;TZID=Europe/Brussels:20250330T235959
DTSTAMP:20250327T110209Z
CREATED:20250225T161924Z
LAST-MODIFIED:20250327T110209Z
UID:10000013-1740787200-1743379199@www.obelis.net
SUMMARY:Canadian RP Deadline – April 2025
DESCRIPTION:The Cosmetic Regulations were amended in April 2024 to – among other things – expand the definition of “manufacturer” to mean:  \n\n\n\n💠A person in Canada who sells the cosmetic under their own name or a trademark\, design\, trade name\, or other mark they own or control. \n\n\n\n💠A person in Canada authorized to act on behalf of a non-Canadian entity that sells the cosmetic under its own name or trademark. \n\n\n\nThis means that\, to sell in Canada\, a brand owner based outside the country must appoint a representative with a Canadian address who assumes the legal obligations of a manufacturer. \n\n\n\nAlthough these amendments have been in force since October 2024\, Health Canada has announced that starting March 2025\, they will officially be enforced with the updated notification form requiring the name and address of the representative for brand owners in Canada. 
URL:https://www.obelis.net/events/canadian-rp-april-2025/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/svg+xml:https://www.obelis.net/wp-content/uploads/2025/02/Event-Calendar-Featured-Image-15.svg
END:VEVENT
END:VCALENDAR